SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample
16 references·1 citing·31 second hop
Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample (2022)Antidepressant effects of a psychedelic e…Trial of Psilocybin versus Escitalopram for Depression (2021)Trial of Psilocybin versus Es…Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)Effects of Psilocybin-Assiste…Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial (2018)Rapid antidepressant effects …Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression (2018)Quality of Acute Psychedelic …Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)Psilocybin with psychological…Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Rapid and sustained symptom r…Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (2016)Psilocybin with psychological…Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Psilocybin produces substanti…Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study (2015)Psilocybin-assisted treatment…Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects (2011)Psilocybin occasioned mystica…Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness (2011)Mystical experiences occasion…Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Pilot Study of Psilocybin Tre…Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008)Mystical-type experiences occ…Human hallucinogen research: guidelines for safety (2008)Human hallucinogen research: …The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression (2003)The 16-Item quick inventory o…The development of a six‐item short‐form of the state scale of the Spielberger State—Trait Anxiety Inventory (STAI) (1992)The development of a six‐item…Therapeutic mechanisms of psychedelics and entactogens (2023)Therapeutic mechanisms of psy…Coefficient Alpha and the Internal Structure of Tests (1951)The Measurement of Observer Agreement for Categorical Data (1977)The Epidemiology of Major Depressive Disorder (2003)Recommendations for a Standard Research Assessment of Insomnia (2006)Prevalence and Distribution of Major Depressive Disorder in African Americans, Caribbean Blacks, and Non-Hispanic Whites (2007)Diagnostic and Statistical Manual of Mental Disorders (2013)The varieties of religious experience: A study in human nature. (1902)Universals in the Content and Structure of Values: Theoretical Advances and Empirical Tests in 20 Countries (1992)Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. (2002)Neural correlates of the LSD experience revealed by multimodal neuroimaging (2016)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)Manual for the State-Trait Anxiety Inventory (1970)Internalized stigma among sexual minority adults: Insights from a social psychological perspective. (2009)Public perceptions, anxiety, and behaviour change in relation to the swine flu outbreak: cross sectional telephone survey (2009)Younger people are more vulnerable to stress, anxiety and depression during COVID-19 pandemic: A global cross-sectional survey (2020)Hallucinogens (2004)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)DSM‐IV‐TR: Diagnostic and Statistical Manual of Mental Disorders (2013)An Inventory for Measuring Depression (1961)The Brief Psychiatric Rating Scale (1962)Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (2012)Psychedelics Promote Structural and Functional Neural Plasticity (2018)The Hospital Anxiety and Depression Scale (1983)Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. (1985)Psychedelics (2016)A RATING SCALE FOR DEPRESSION (1960)The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults (2011)Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo (2021)Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder (2022)Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression (2022)Single-Dose Psilocybin Treatment for Major Depressive Disorder (2023)
this work references cited by second hop

References

  • 2003The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression3,828 cited
  • 1992The development of a six‐item short‐form of the state scale of the Spielberger State—Trait Anxiety Inventory (STAI)3,244 cited
  • 2016Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial2,196 cited
  • 2016Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial1,696 cited
  • 2016Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study1,533 cited
  • 2021Trial of Psilocybin versus Escitalopram for Depression1,386 cited
  • 2020Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder1,296 cited
  • 2010Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer1,205 cited
  • 2008Human hallucinogen research: guidelines for safety1,201 cited
  • 2015Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study1,150 cited
  • 2017Psilocybin with psychological support for treatment-resistant depression: six-month follow-up969 cited
  • 2011Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects932 cited
  • 2008

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
901 cited
  • 2011Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness893 cited
  • 2018Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial851 cited
  • 2018Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression806 cited
  • Cited by

    • 2023Therapeutic mechanisms of psychedelics and entactogens71 cited